A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

BACKGROUND: We have previously shown that a panel of kallikrein markers - total prostate-specific antigen (PSA), free PSA, intact PSA and human kallikrein-related peptidase 2 (hK2) - can predict the outcome of prostate biopsy in men with elevated PSA. Here we investigate the properties of our panel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Benchikh, Amine, Savage, Caroline, Cronin, Angel, Salama, Gilles, Villers, Arnauld, Lilja, Hans, Vickers, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2996396/
https://ncbi.nlm.nih.gov/pubmed/21092177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-635
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados